Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pierre Fabre Pharma Norden AB
AB
Active
Org 5565179305
Karlavägen 108, 115 26
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pierre Fabre Pharma Norden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
70M
140M
210M
279M
187M
2020
208M
2021
243M
2022
208M
2023
241M
2024
EBITDA
SEK millions
0M
3M
5M
8M
10M
8M
2020
6M
2021
9M
2022
6M
2023
8M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
187 092
207 807
242 913
208 091
240 572
Staff expenses
—
—
—
—
—
EBITDA
7 664
6 173
8 857
6 078
7 785
Depreciation & amort.
−151
−95
−222
−63
−53
EBIT
7 513
6 078
8 635
6 015
7 732
Net financials
−525
−565
−579
344
842
Profit before tax
6 987
5 799
8 056
6 359
8 574
Tax
577
−2 469
−2 448
−2 036
−1 718
Net profit
7 564
3 330
5 608
4 323
6 856
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
136 673
145 289
130 312
156 766
186 951
Equity
24 325
19 651
25 259
24 187
31 043
Long-term debt
15 000
0
0
0
0
Short-term debt
97 348
125 637
105 053
132 579
155 908
Total debt
112 348
125 637
105 053
132 579
155 908
Financial ratios
5-year trend
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
2020
2024
Equity ratio
16.6%
This company
38.2%
Market median
-57% vs market
2020
2024
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
2020
2024
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
2020
2024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
2020
2024
Debt / equity
5.02×
This company
0.62×
Market median
-710% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pierre Fabre Pharma Norden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
